For the active substances cyflufenamid and fenazaquin, maximum residue levels (‘MRLs’) were set in Annex II to Regulation (EC) No 396/2005. For the active substance nicotine, temporary MRLs were set in Part A of Annex III to that Regulation.
Recital 1, Regulation (EU) 2026/742
In forcesince 30 Mar 2026